Christine Tunon De Lara

Summary

Affiliation: Institut Bergoni
Country: France

Publications

  1. pmc An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis
    Françoise Bonnet
    Inserm U 916 Institut Bergonié, Universite de Bordeaux, Bordeaux, France
    BMC Med Genomics 5:54. 2012
  2. pmc Breast cancer care compared with clinical Guidelines: an observational study in France
    Marie Lebeau
    Pôle de Cancérologie, Hématologie et Pathologie Tissulaire, Service de Radiotherapie, CHU de Poitiers, France
    BMC Public Health 11:45. 2011
  3. doi request reprint Ductal carcinoma in situ of the breast: influence of age on diagnostic, therapeutic, and prognostic features. Retrospective study of 812 patients
    Christine Tunon-de-Lara
    Department of Surgery, Institut Bergonie, Bordeaux Cedex, France
    Ann Surg Oncol 18:1372-9. 2011
  4. doi request reprint Ductal carcinoma in situ of the breast in younger women: a subgroup of patients at high risk
    C Tunon-de-Lara
    Department of Surgery, Institut Bergonie, 229 Cours de l Argonne, 33076 Bordeaux Cedex, France
    Eur J Surg Oncol 36:1165-71. 2010
  5. doi request reprint [Ductal carcinoma in situ of the breast (DCIS) under 40: a specific management?]
    C Tunon De Lara
    Service de Chirurgie, Institut Bergonie, 229, cours de l Argonne, 33076 Bordeaux Cedex, France
    Gynecol Obstet Fertil 36:499-506. 2008
  6. doi request reprint [Male breast cancer: a review of 52 cases collected at the Institute Bergonié (Bordeaux, France) from 1980 to 2004]
    C Tunon De Lara
    Service de Chirurgie, Institut Bergonie, centre régional de lutte contre le cancer CRLCC, 229, cours de l Argonne, 33076 Bordeaux Cedex, France
    Gynecol Obstet Fertil 36:386-94. 2008
  7. doi request reprint Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy
    Christine Tunon-de-Lara
    Department of Surgery, Bergonie Institute Cancer Centre, Bordeaux Cedex, France
    Breast J 14:135-40. 2008
  8. doi request reprint Is it useful to detect lymphovascular invasion in lymph node-positive patients with primary operable breast cancer?
    Florence Ragage
    Department of Pathology, Bergonie Institute, Regional Cancer Center, Bordeaux Cedex, France
    Cancer 116:3093-101. 2010
  9. ncbi request reprint [Bilateral ductal carcinoma in situ of the breast: independent events or bilateral disease?]
    G Andre
    Service de Chirurgie, Institut Bergonie, 229, cours de l Argonne, Bordeaux, France
    J Gynecol Obstet Biol Reprod (Paris) 36:260-6. 2007
  10. pmc Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer
    Carine A Bellera
    Department of Clinical Epidemiology and Clinical Research, Institut Bergonie, Regional Comprehensive Cancer Centre, Bordeaux, France
    BMC Med Res Methodol 10:20. 2010

Collaborators

Detail Information

Publications15

  1. pmc An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis
    Françoise Bonnet
    Inserm U 916 Institut Bergonié, Universite de Bordeaux, Bordeaux, France
    BMC Med Genomics 5:54. 2012
    ..Several reports indicate that genomic instability, as reflected in specific chromosomal aneuploidies and variations in DNA content, influences clinical outcome but no precise definition of this parameter has yet been clearly established...
  2. pmc Breast cancer care compared with clinical Guidelines: an observational study in France
    Marie Lebeau
    Pôle de Cancérologie, Hématologie et Pathologie Tissulaire, Service de Radiotherapie, CHU de Poitiers, France
    BMC Public Health 11:45. 2011
    ..In two French regions, we measured compliance with Clinical Practice Guidelines for non-metastatic BC care management and identified factors associated with non-compliance at clinical and organisational levels...
  3. doi request reprint Ductal carcinoma in situ of the breast: influence of age on diagnostic, therapeutic, and prognostic features. Retrospective study of 812 patients
    Christine Tunon-de-Lara
    Department of Surgery, Institut Bergonie, Bordeaux Cedex, France
    Ann Surg Oncol 18:1372-9. 2011
    ..The objective of this retrospective study was to identify prognostic, diagnostic, and therapeutic disparities between younger (≤ 40 years) and older (> 40 years) women with ductal carcinoma in situ (DCIS) of the breast...
  4. doi request reprint Ductal carcinoma in situ of the breast in younger women: a subgroup of patients at high risk
    C Tunon-de-Lara
    Department of Surgery, Institut Bergonie, 229 Cours de l Argonne, 33076 Bordeaux Cedex, France
    Eur J Surg Oncol 36:1165-71. 2010
    ..The purpose of this study was to evaluate predictive factors for recurrence and outcomes in these younger women (under 40 years) treated for pure DCIS...
  5. doi request reprint [Ductal carcinoma in situ of the breast (DCIS) under 40: a specific management?]
    C Tunon De Lara
    Service de Chirurgie, Institut Bergonie, 229, cours de l Argonne, 33076 Bordeaux Cedex, France
    Gynecol Obstet Fertil 36:499-506. 2008
    ..Radiotherapy with boost or hormonotherapy with tamoxifen should not be used routinely but may be proposed individually...
  6. doi request reprint [Male breast cancer: a review of 52 cases collected at the Institute Bergonié (Bordeaux, France) from 1980 to 2004]
    C Tunon De Lara
    Service de Chirurgie, Institut Bergonie, centre régional de lutte contre le cancer CRLCC, 229, cours de l Argonne, 33076 Bordeaux Cedex, France
    Gynecol Obstet Fertil 36:386-94. 2008
    ..To analyze the characteristics and to establish prognosis factors for 52 men suffering from breast cancer from 1980 to 2004...
  7. doi request reprint Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy
    Christine Tunon-de-Lara
    Department of Surgery, Bergonie Institute Cancer Centre, Bordeaux Cedex, France
    Breast J 14:135-40. 2008
    ..We need to focus on the subgroup with or a high risk of occult MIC: extensive calcifications or palpable mass, DCIS diagnosed by core biopsy and underestimation, multifocality, high grade, large tumor size, MIC, and mastectomy...
  8. doi request reprint Is it useful to detect lymphovascular invasion in lymph node-positive patients with primary operable breast cancer?
    Florence Ragage
    Department of Pathology, Bergonie Institute, Regional Cancer Center, Bordeaux Cedex, France
    Cancer 116:3093-101. 2010
    ..Lymphovascular invasion (LVI) is a widely recognized prognostic factor in lymph node-negative breast cancers. However, there are only limited and controversial data about its prognostic significance in lymph node-positive patients...
  9. ncbi request reprint [Bilateral ductal carcinoma in situ of the breast: independent events or bilateral disease?]
    G Andre
    Service de Chirurgie, Institut Bergonie, 229, cours de l Argonne, Bordeaux, France
    J Gynecol Obstet Biol Reprod (Paris) 36:260-6. 2007
    ..In a retrospective study of bilateral Ductal Carcinoma In Situ (DCIS), cases were analysed to determine the relationship between the two events...
  10. pmc Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer
    Carine A Bellera
    Department of Clinical Epidemiology and Clinical Research, Institut Bergonie, Regional Comprehensive Cancer Centre, Bordeaux, France
    BMC Med Res Methodol 10:20. 2010
    ..We emphasize the importance of this assumption and the misleading conclusions that can be inferred if it is violated; this is particularly essential in the presence of long follow-ups...
  11. ncbi request reprint Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations
    Béatrice Barreau
    Department of Radiology, Institut Bergonie, Regional Cancer Center, 229, cours de l Argonne, 33076 Bordeaux Cedex, France
    Eur J Radiol 54:55-61. 2005
    ..Mammographic size was correlated to histologic size. Masses were correlated with grade 1. A diagnosis strategy can be proposed with a multidisciplinar approach...
  12. doi request reprint Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up
    A Avril
    Department of Surgery, Institut Bergonie, 229 Cours de l Argonne, 33076 Bordeaux Cedex, France
    Eur J Surg Oncol 37:563-70. 2011
    ....
  13. ncbi request reprint Number of residual nodules, better than size, defines optimal surgery in advanced epithelial ovarian cancer
    E Stoeckle
    Department of Surgery, Institut Bergonie, Regional Cancer Center, 33076 Bordeaux Cedex, France
    Int J Gynecol Cancer 14:779-87. 2004
    ..Otherwise, cytoreduction leaving numerous nodules, whatever their size, remains suboptimal. Such patients should be considered for neo-adjuvant chemotherapy...
  14. ncbi request reprint Analysis of 676 cases of ductal carcinoma in situ of the breast from 1971 to 1995: diagnosis and treatment--the experience of one institute
    C Tunon-de-Lara
    Department of Surgery, , Regional Cancer Center, Bordeaux, France
    Am J Clin Oncol 24:531-6. 2001
    ..All the recurrence in patients with positive margins was in the same quadrant as the original lesion. This further emphasizes the need for clear margins...
  15. ncbi request reprint Evaluation of a preoperative multimedia information program in surgical oncology
    S Evrard
    Department of Surgical Oncology, Institut Bergonie, Comprehensive Cancer Center, Bordeaux, France
    Eur J Surg Oncol 31:106-10. 2005
    ..We report on the design, validation and evaluation of a DVD for patient information in a department of surgical oncology...